Lv2
142 积分 2026-03-24 加入
Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection
1个月前
已完结
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
1个月前
已完结
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
2个月前
已完结
Liver disease in people living with HIV infection: a changing landscape
2个月前
已完结
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial
4个月前
已完结
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial
5个月前
已完结
皖公网安备34019202002308
